Endocrine Abstracts

It is known that in type 1 diabetes mellitus (T1DM) continuous subcutaneous insulin infusion (CSII) therapy improves metabolic control and reduces risk of hypoglycaemia in comparison with multiple daily injection (MDI). Metabolic outcomes usually considered are HbA1c, BMI, and inflammatory parameters. However few data are available on pituitary and gonadal hormone responses, which are involved in metabolic processes. In order to study the response of anabolic hormones in patie...

Background: red blood cells (RBC) membrane fluidity in patients with type 2 diabetes mellitus (T2DM) can be influenced by various factors like oxidative stress, aging, glycosylation, lipid homeostasis and exposure to nutrients.Objective: To analyze RBC membrane fluidity in patients with long-duration T2DM (more than 10 years), looking for any differences between patients without and with macroangiopathy (vascular diabetic foot).Met...